Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine modelsPaola Rivera-Muñoz(Inserm), Sébastien Malinge(The Kids Research Institute Australia)Blood AdvancesJuly 9, 201810.1182/bloodadvances.2018016089Cited by 13SaveCiteExport RISWatch citationsRelated PapersGenetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies|Blood|2009|718